Semen Indonesia stock jumps on 471% profit surge and restructuring plan
Published on 09/01/2026 at 07:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Semen Indonesia (ISIN ID1000060007) is back in the spotlight on September 1, 2026 after reporting a 471.13% year-over-year jump in net profit for the first half of 2026 and outlining a tight timetable to merge seven subsidiaries into PT Semen Indonesia Distributor.
According to a same-day earnings summary based on the companys latest financial statements, revenue for the first half of 2026 reached IDR17.64 trillion, up from IDR15.60 trillion in the first half of 2025, while net profit attributable to owners of the parent climbed from IDR39.97 billion to IDR228.25 billion over the same period. The earnings recap highlights the stronger top line and profitability.
First-half 2026 results show sharp earnings recovery
The detailed breakdown of the first-half 2026 figures shows that Semen Indonesia generated IDR17.64 trillion in revenue for the six months ended June 30, 2026 compared with IDR15.60 trillion in the prior-year period, an increase of IDR2.04 trillion that reflects stronger cement volumes and firmer pricing in its domestic market. This revenue growth context is laid out in the financial-portal summary.
Cost of goods sold rose to IDR13.85 trillion in the first half of 2026 from IDR12.47 trillion a year earlier, but gross profit still improved from IDR3.13 trillion to IDR3.79 trillion, illustrating that the company managed to expand its gross profit by IDR0.66 trillion despite higher input costs. The same report shows that profit before tax increased from IDR155.27 billion to IDR392.39 billion, underlining a wider operating cushion.
For equity holders, the most striking metric is net profit attributable to owners of the parent, which advanced from IDR39.97 billion in the first half of 2025 to IDR228.25 billion in the first half of 2026. That equates to a 471.13% year-over-year gain and marks a meaningful recovery in profitability after a tougher prior period. A separate coverage of the results notes that earnings per share rose from IDR6 to IDR34 over the same timeframe, reinforcing that the turnaround is visible at the per-share level as well. The earnings-per-share improvement is highlighted in another market report.
Balance sheet trends and valuation backdrop
Alongside the stronger income statement, Semen Indonesias balance sheet at June 30, 2026 shows total liabilities of IDR25.24 trillion, down from IDR27.14 trillion as of December 31, 2025, indicating that the company has reduced its obligations by IDR1.90 trillion over the six-month period. Total assets declined from IDR76.56 trillion at year-end 2025 to IDR74.62 trillion at mid-2026, a modest decrease that still leaves the group with a sizeable asset base supporting its operations.
Market commentary on September 1, 2026 points out that Semen Indonesia shares ended the prior trading session on August 31, 2026 at IDR1,480, representing a 1.33% decline on the day, and implying that the stock is being valued at a price-to-book ratio of 0.23 based on its reported equity. This overview frames Semen Indonesia as a low price-to-book value play despite its IDR17.6 trillion revenue base in the first half of 2026.
Another market-focused daily note dated August 31, 2026 lists Semen Indonesia at IDR1,500 per share with a market capitalization of IDR10,127 billion, underscoring that even small price steps translate into substantial changes in equity value for the cement producer. That same snapshot portrays the company as a multi-trillion-rupiah player in Indonesias equity market.
Research commentary grouped with these figures notes that analysts see the 471% earnings rebound in the first half of 2026 as driven by both higher cement volumes and improved average selling prices. One equity-research team maintains a positive rating and a target price of IDR1,900 per share, implying upside of 28.4% from the IDR1,480 closing price on August 31, 2026 if that objective is reached, a gap that illustrates the perceived undervaluation based on the new earnings base. The research snapshot ties the rating directly to the first-half 2026 profit surge.
Seven-subsidiary merger aims to streamline distribution
Beyond the headline earnings, Semen Indonesia is also moving ahead with a significant internal restructuring that will merge seven subsidiaries, including Semen Kupang Indonesia and Semen Indonesia International, into PT Semen Indonesia Distributor (SID). A detailed restructuring report lists the full roster of entities slated for consolidation into SID.
The indicative timetable for the merger sets September 1, 2026 for the publication of a summary of the merger plan in at least one newspaper and for delivering written notification to employees, while September 15, 2026 is designated as the deadline for creditors to submit objections. Corporate-approval and creditor-approval processes are targeted for completion on September 18, 2026, meaning that key legal and governance milestones are clustered within less than three weeks.
An equity strategy note summarizing the same plan explains that the consolidation is part of a broader restructuring initiative across state-linked industrial groups, with the goal of simplifying subsidiary structures, concentrating distribution activities under SID, and potentially reducing overlapping costs. This snapshot stresses that Semen Indonesias seven-company merger into SID fits within a wider state-backed rationalization of cement assets.
For investors, the merger timetable adds an operational narrative on top of the financial recovery, as the company attempts to align its corporate structure with its role as a national cement champion. If the merger proceeds as scheduled, the group could see a more streamlined distribution chain by late 2026, potentially supporting margins in future reporting periods.
Product spotlight - Semen Indonesia bagged cement
Semen Indonesias core business revolves around producing and distributing cement products used in infrastructure, residential, and commercial construction across Indonesia and export markets. Among its representative offerings is its flagship bagged Portland cement sold under the Semen Indonesia and Semen Gresik brands, which is widely used in housing projects, roadwork, and small-scale construction throughout the archipelago.
The company also supplies bulk cement to large industrial and infrastructure customers, feeding demand from toll-road projects, ports, and other state-backed developments. This dual-channel approach positions Semen Indonesia to benefit both from ongoing government infrastructure programs and from private real estate investment cycles, making its volume trends a key indicator for the broader Indonesian construction economy.
Semen Indonesia stock and current market context
Semen Indonesia shares trade on the Indonesia Stock Exchange in rupiah, and recent market data from August 31, 2026 show the stock at IDR1,480 with a price move of minus 1.33% on that session, a level only slightly below the IDR1,500 reference cited in a daily focus sheet. Taken together, these prices frame the stock within a narrow trading band around IDR1,500 while analysts flag the valuation gap to their IDR1,900 target level.
With first-half 2026 revenue of IDR17.64 trillion, net profit attributable to owners of the parent of IDR228.25 billion, and a balance-sheet reduction in liabilities to IDR25.24 trillion by June 30, 2026, the latest set of figures presents Semen Indonesia as a recovering cement producer that is simultaneously undertaking a sizeable internal restructuring of its distribution subsidiaries. For investors tracking Semen Indonesia stock, the combination of a 471.13% earnings rebound and the upcoming September 2026 merger milestones will likely be central themes over the coming weeks.
Fact box
Company: Semen Indonesia
ISIN: ID1000060007
Ticker: SMGR
Exchange: Indonesia Stock Exchange (IDX)
Sector / Industry: Materials / Construction materials
